Lista de

memantine
7
"Pharmacological approaches to the treatment of tinnitus" (2010) Elgoyhen, A.B.; Langguth, B. Drug Discovery Today. 15(7-8):300-305
"Inhibition of the α9α10 nicotinic cholinergic receptor by neramexane, an open channel blocker of N-methyl-d-aspartate receptors" (2007) Plazas, P.V.;Savino, J.;Kracun, S. (...)Elgoyhen, A.B. European Journal of Pharmacology. 566(1-3):11-19
"Inhibition of the α9α10 nicotinic cholinergic receptor by neramexane, an open channel blocker of N-methyl-d-aspartate receptors" (2007) Plazas, P.V.;Savino, J.;Kracun, S. (...)Elgoyhen, A.B. European Journal of Pharmacology. 566(1-3):11-19
"Inhibition of the α9α10 nicotinic cholinergic receptor by neramexane, an open channel blocker of N-methyl-d-aspartate receptors" (2007) Plazas, P.V.;Savino, J.;Kracun, S. (...)Elgoyhen, A.B. European Journal of Pharmacology. 566(1-3):11-19
"Effect of memantine (NMDA antagonist) on Parkinson's disease: A double- blind crossover randomized study" (1999) Merello, M.; Nouzeilles, M.I.; Cammarota, A.; Leiguarda, R. Clinical Neuropharmacology. 22(5):273-276
"Effect of memantine (NMDA antagonist) on Parkinson's disease: A double- blind crossover randomized study" (1999) Merello, M.; Nouzeilles, M.I.; Cammarota, A.; Leiguarda, R. Clinical Neuropharmacology. 22(5):273-276
"Effect of memantine (NMDA antagonist) on Parkinson's disease: A double- blind crossover randomized study" (1999) Merello, M.; Nouzeilles, M.I.; Cammarota, A.; Leiguarda, R. Clinical Neuropharmacology. 22(5):273-276